Key Points
-
Chemoprevention is defined as the use of pharmacological agents (including nutrients) to impede, arrest or reverse carcinogenesis and has been used to test the efficacy of numerous nutrients and other dietary factors.
-
Observational epidemiology and experimentation by randomized controlled trials (RCTs) have been used to evaluate dietary factors in cancer chemoprevention; however, consistency in findings has been elusive.
-
The study of diet and cancer associations in humans poses a variety of challenges owing to the complexity in measuring dietary intake as well as the multifactorial nature of the cancer endpoints.
-
In several circles, RCTs are viewed as being more credible than observational studies.
-
When discrepant results between observational studies and RCTs are reported, careful consideration needs to be given to the details of each set of studies before accepting RCTs as valid and those of observational studies as biased.
-
Considerations in the interpretation of results from RCTs include the background diet of the study population; the dose, duration and timing of the intervention; the precise form of the nutrient or dietary factor tested; and compliance with the intervention.
Abstract
Observational epidemiology and experimentation by randomized controlled trials (RCTs) have been used to evaluate dietary factors in cancer prevention; however, consistency in findings has been elusive. In several circles, RCTs are viewed as more credible than observational studies. As the testing of dietary epidemiological findings in RCTs has been more common for colorectal cancer than for other cancers, we use experience with this malignancy to critically appraise the reasons for discrepancies between results of observational and experimental studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Doll, R. & Peto, R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst. 66, 1191–1308 (1981). This landmark publication revolutionized the area of cancer aetiology related to lifestyle and environmental factors. The authors provided for the first time quantitative estimates that, although crude, emphasized that cancer was avoidable.
World Cancer Research Fund/American Institute for Cancer Research. Second Expert Report (AICR, Washington, D. C., 2007). In this second edition, international data from published studies of diet and cancer are summarized systematically (through meta-analyses) and results are interpreted to provide individual and policy recommendations.
Flood, D. M. et al. Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 11, 403–411 (2000).
Willett, W. C. Goals for nutrition in the year 2000. Ca. Cancer J. Clin. 49, 331–352 (1999).
Bresalier, R. S. Chemoprevention of colorectal cancer: Why all the confusion? Curr. Opin. Gastroenterol. 24, 48–50 (2008).
Meyskens, F. L., Jr & Szabo, E. Diet and cancer: The disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol. Biomarkers Prev. 14, 1366–1369 (2005).
Shekelle, P. et al. in AHRQ Publication No. 03-E047 (Agency for Healthcare Research and Quality, Rockville, USA, 2003).
Schachter, H. M. et al. in AHRQ Publication No. 04-E013-2 (Agency for Healthcare Research and Quality, Rockville, USA, 2004).
Graham, S. et al. Diet in the epidemiology of postmenopausal breast cancer in a New York State cohort. Am. J. Epidemiol. 136, 1327 (1992).
Slattery, M. et al. Energy balance and colon cancer — beyond physical activity. Cancer Res. 57, 75–80 (1997).
Omenn, G. S. et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334, 1150–1155 (1996).
Marshall, J. R. & Hastrup, J. L. Mismeasurement and resonance of strong confounders: Uncorrelated errors. Am. J. Epidemiol. 143, 1069–1078 (1996).
Willett, W. C. (ed.) Nutritional epidemiology (Oxford University Press, New York, 1998).
Martínez, M. E. et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J. Natl Cancer Inst. 88, 1375–1382 (1996).
Fuchs, C. S. et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med. 340, 169–176 (1999).
Slattery, M. L. et al. Energy balance, insulin-related genes and risk of colon and rectal cancer. Int. J. Cancer 215, 148–154 (2005).
The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330, 1029–1035 (1994).
Pierce, J. P. et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The women's healthy eating and living (WHELl) randomized trial. JAMA 298, 289–298 (2007).
Sporn, M. B. Carcinogenesis and cancer: Different perspectives on the same disease. Cancer Res. 51, 6215–6218 (1991). This landmark article describes the concept behind chemoprevention.
Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990). This article describes the adenoma-to-carcinoma multi-step sequence, which is described in Fig. 2 of the manuscript.
Morson, B. C. Evolution of cancer of the colon and rectum. Cancer 34 (Suppl), 845–849 (1974).
Muto, T., Bussey, H. J. & Morson, B. C. The evolution of cancer of the colon and rectum. Cancer 36, 2251–2270 (1975).
Stryker, S. J. et al. Natural history of untreated colonic polyps. Gastroenterology 93, 1009–1013 (1987).
Leslie, A., Carey, F. A., Pratt, N. R. & Steele, R. J. C. The colorectal adenoma–carcinoma sequence. Br. J. Surg. 89, 845–865 (2002).
Wagner, C. Symposium on the subcellular compartmentation of folate metabolism. J. Nutr. 126, 1228S–1234S (1996).
Choi, S. W. & Mason, J. B. Folate status: Effects on pathways of colorectal carcinogenesis. J. Nutr. 132, 2413S–2418S (2002).
Duthie, S. J. Folic acid deficiency and cancer: Mechanisms of DNA instability. Br. Med. Bull. 55, 578–592 (1999).
Kim, Y. I. Folate and carcinogenesis: Evidence, mechanisms, and implications. J. Nutr. Biochem. 10, 66–88 (1999).
Martinez, M. E. et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int. J. Cancer 119, 1140–1446 (2006).
Martinez, M. E., Henning, S. M. & Alberts, D. S. Folate and colorectal neoplasia: Relationship between plasma and dietary markers of folate and adenoma recurrence. Am. J. Clin. Nutr. 79, 691–697 (2004).
Glynn, S. A. et al. Colorectal cancer and folate status: A nested case-control study among male smokers. Cancer Epidemiol. Biomarkers Prev. 5, 487–494 (1996).
Kato, I. et al. Serum folate, homocysteine and colorectal cancer risk in women: A nested case-control study. Br. J. Cancer 79, 1917–1921 (1999).
Bailey, L. B. Dietary reference intakes for folate: The debut of dietary folate equivalents. Nutr. Rev. 56, 294–299 (1998).
Sanjoaquin, M. A., Allen, N., Couto, E., Roddam, A. W. & Key, T. J. Folate intake and colorectal cancer risk: A meta-analytical approach. Int. J. Cancer 113, 825–828 (2005).
Cole, B. F. et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 297, 2351–2359 (2007).
Logan, R. F. et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134, 29–38 (2008).
Kim, Y. I. Role of folate in colon cancer development and progression. J. Nutr. 133, 3731S–3739S (2003).
Cravo, M. L. et al. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52, 5002–5006 (1992).
Kim, Y.-I. et al. Dietary folate protectects against the development of macroscopic colonic neoplasia in a dose responsive manner in rates. Gut 39, 732–740 (1996).
Le Leu, R. K., Young, G. P. & McIntosh, G. H. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21, 2261–2265 (2000).
Song, J., Medline, A., Mason, J. B., Gallinger, S. & Kim, Y.-I. Effects of dietry folate on intestinal tumorigenesis in the Apcmin mouse. Cancer Res. 60, 5434–5440 (2000).
Ulrich, C. M. & Potter, J. D. Folate and cancer — timing is everything. JAMA. 297, 2408–2409 (2007).
Wu, K. et al. in Proc. 99th Annu. Meeting Am. Assoc. Cancer Res. LB–78 (San Diego, USA, 2008).
Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D. & Wong, L.-Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285, 2981–2986 (2001).
Newmark, H. L., Wargowich, M. J. & Bruce, W. R. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J. Natl Cancer Inst. 72, 1323–1325 (1984).
Norat, T. & Riboli, E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur. J. Clin. Nutr. 57, 1–17 (2003).
Cho, E. et al. Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies. J. Natl. Cancer Inst. 96, 1015–1022 (2004). This article presents results of pooled prospective studies of calcium and colorectal cancer.
Peters, U. et al. Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am. J. Clin. Nutr. 80, 1358–1365 (2004).
Kesse, E. et al. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3N-Epic prospective study. Int. J. Cancer 117, 137–144 (2005).
Oh, K., Willett, W. C., Wu, K., Fuchs, C. S. & Giovannucci, E. L. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am. J. Epidemiol. 165, 1178–1186 (2007).
Hartman, T. J. et al. The association of calcium and vitamin D with risk of colorectal adenomas. J. Nutr. 135, 252–259 (2005).
Baron, J. A. et al. Calcium supplements for the prevention of colorectal adenomas. N. Engl. J. Med. 340, 101–107 (1999).
Bonithon-Kopp, C., Kronborg, O., Giacosa, A., Rath, U. & Faivre, J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: A randomized intervention trial. European cancer prevention organisation study group. Lancet 356, 1300–1306 (2000).
Hofstad, B. et al. The relationship between faecal bile acid profile with or without supplementation with calcium and antioxidants on recurrence and growth of colorectal polyps. Eur. J. Cancer Prev. 7, 287–294 (1998).
Wactawski-Wende, J. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684–696 (2006). This article presents the results of the WHI RCT of calcium and colorectal cancer.
Martinez, M. E. & Willett, W. C. Calcium, vitamin D, and colorectal cancer: A review of the epidemiologic evidence. Cancer Epidemiol, Biomarkers Prev 7, 163–168 (1998).
Wu, K., Willett, W. C., Fuchs, C. S., Colditz, G. A. & Giovannucci, E. L. Calcium intake and risk of colon cancer in women and men. J. Natl Cancer Inst. 94, 437–446 (2002).
Burkitt, D. P. Epidemiology of cancer of the colon and rectum. Cancer 28, 3–13 (1971).
Park, Y. et al. Dietary fiber intake and risk of colorectal cancer: A pooled analysis of prospective cohort studies. JAMA 294, 2849–2857 (2005).
Peters, U. et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361, 1491–1495 (2003). This article presents an observational study that assesses dietary fibre and colorectal adenoma prevalence.
Bingham, S. A. et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. Lancet 361, 1496–1501 (2003). This article presents results of an observational study of dietary fibre and colorectal cancer.
Alberts, D. S. et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix colon cancer prevention physicians' network. N. Engl. J. Med. 342, 1156–1162 (2000). This article presents the results of one of the RCTs of fibre and colorectal adenoma.
Schatzkin, A. et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp prevention trial study group. N. Engl. J. Med. 342, 1149–1155 (2000).
Beresford, S. A. et al. Low-fat dietary pattern and risk of colorectal cancer: The women's health initiative randomized controlled dietary modification trial. JAMA 295, 643–654 (2006).
Giacosa, A., Franceschi, S., La Vecchia, C., Favero, A. & Andreatta, R. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur. J. Cancer Prev. 8 (Suppl. 1), 53S–60S (1999).
Larsson, S. C. & Wolk, A. Meat consumption and risk of colorectal cancer: A meta-analysis of prospective studies. Int. J. Cancer 119, 2657–2664 (2006).
Norat, T. & Riboli, E. Meat consumption and colorectal cancer: A review of epidemiologic evidence. Nutr. Rev. 59, 37–47 (2001).
Sacks, F. M. & Katan, M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am. J. Med. 113, 13S–24S (2002).
Shrier, I. et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am. J. Epidemiol. 166, 1203–1209 (2007).
Prentice, R. L. et al. Low-fat dietary pattern and risk of invasive breast cancer: The Women's Health Initiative randomized controlled dietary modification trial. JAMA 295, 629–642 (2006).
Troen, A. M. et al. Unmetabolized folic acid in plasma is associated with reduced naturalkiller cell cytotoxicity among postmenopausal women. J. Nutr. 136, 189–194 (2006).
Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nature Immunol. 9, 503–510 (2008).
Byers, T. What can randomized controlled trials tell us about nutrition and cancer prevention? CA Cancer J. Clin. 49, 353–361 (1999). An excellent summary related to interpretation of results from RCTs that have tested efficacy of dietary factors as preventive agents.
Giovannucci, E. Nutrition, insulin, insulin-like growth factors and cancer. Horm. Metab. Res. 35, 694–704 (2003).
Thun, M. J., Henley, S. J. & Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J. Natl Cancer Inst. 94, 252–266 (2002).
Chan, A. T. Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: Future challenges in chemoprevention. Cancer Causes Control 14, 413–418 (2003).
Baron, J. A. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog. Exp. Tumor Res. 37, 1–24 (2003).
Huls, G., Koornstra, J. J. & Kleibeuker, J. H. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362, 230–232 (2003).
Giovannucci, E. et al. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121, 241–246 (1994).
Giovannucci, E. et al. Aspirin use and risk of colorectal cancer in women. N. Engl. J. Med. 333, 609–614 (1995).
Larsson, S. C., Giovannucci, E. & Wolk, A. Long-term aspirin use and colorectal cancer risk: A cohort study in Sweden. Br. J. Cancer 95, 1277–1279 (2006).
Chan, A. T. et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294, 914–923 (2005).
Tangrea, J. A. et al. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 14, 403–411 (2003).
Baron, J. A. et al. A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348, 891–899 (2003).
Sandler, R. S. et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N. Engl. J. Med. 348, 883–890 (2003).
Benamouzig, R. et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125, 328–336 (2003).
Gann, P. H., Manson, J. E., Glynn, R. J., Buring, J. E. & Hennekens, C. H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J. Natl Cancer Inst. 85, 1220–1224 (1993).
Cook, N. R. et al. Low-dose aspirin in the primary prevention of cancer: The women's health study: A randomized controlled trial. JAMA 294, 47–55 (2005).
Flossman, E., Rothwell, P. M. & British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet 369, 1603–1613 (2007).
Byers, T. Diet, colorectal adenomas, and colorectal cancer. N. Engl. J. Med. 343, 1206–1207 (2000).
Papadimitrakopoulou, V. A. & Hong, W. K. Retinoids in head and neck chemoprevention. Proc. Soc. Exp. Biol. Med. 216, 283–290 (1997).
Correa, P. et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J. Natl Cancer Inst. 92, 1881–1888 (2000).
Heimburger, D. C. et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 259, 1525–1530 (1988).
Butterworth, C. E. et al. Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial. Am. J. Obstet. Gynecol. 166, 803–809 (1992).
Vogelstein, B. & Kinzler, K. W. (eds) The Genetic Basis of Human Cancer (McGraw Hill Medical Publishing Division, New York, 2002).
Greenberg, E. R. et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med. 331, 141–147 (1994).
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
DATABASES
National Cancer Institute
Glossary
- Confounder
-
A factor that is associated with both an exposure factor and disease outcome such that it distorts or masks the true effect of exposure in an epidemiological study.
- Colonoscopy
-
A procedure usually performed by a gastroenterologist that allows him/her to look inside the colon.
- Polypectomy
-
Removal of one or more polyps, usually by colonoscopy.
- Metachronous adenomas
-
Multiple separate adenomas developing at different intervals.
- Adenoma recurrence
-
A model commonly used to test chemopreventive properties of a variety of agents. Study participants include individuals who have undergone colonoscopy and polypectomy of all lesions visualized and are followed prospectively for the development of metachronous and/or recurrent adenomas.
- Polyglutamation
-
The addition of multiple glutamic acid residues by an enzymatic process. The polyglutamated folates have greater metabolic activity and are retained better in cells.
- Ispaghula husk
-
Also known as psyllium, this is a bulk-forming laxative used to treat constipation and is a dietary source of soluble fibre.
- Natural killer cells
-
A type of lymphocyte that attacks and kills tumour cells and protects against infectious microbes. The term 'natural' is used because they do not need additional stimulation in order to attack and kill.
- Hyperinsulinaemia
-
The presence of an abnormally high level of insulin in the blood. This is usually caused by insulin resistance, a condition in which the body cannot use insulin properly.
- Glycaemic load
-
An indicator of glucose response or insulin demand that is induced by total carbohydrate intake. It is calculated by multiplying the weighted mean of the dietary glycaemic index by the percentage of total energy from carbohydrate.
Rights and permissions
About this article
Cite this article
Martínez, M., Marshall, J. & Giovannucci, E. Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer 8, 694–703 (2008). https://doi.org/10.1038/nrc2441
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc2441
This article is cited by
-
In vitro anti-proliferative activity of selected nutraceutical compounds in human cancer cell lines
BMC Research Notes (2021)
-
Nutritional epidemiology and cancer: A Tale of Two Cities
Cancer Causes & Control (2018)
-
Comparative analysis of nutritional guidelines for vitamin D
Nature Reviews Endocrinology (2017)
-
Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
Scientific Reports (2016)
-
Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior
Current Colorectal Cancer Reports (2015)